Zeo ScientifiX, Inc. (ZEOX)
OTCMKTS · Delayed Price · Currency is USD
1.500
-0.030 (-1.96%)
Sep 12, 2025, 4:00 PM EDT
Zeo ScientifiX Revenue
Zeo ScientifiX had revenue of $1.31M in the quarter ending July 31, 2025, with 19.71% growth. This brings the company's revenue in the last twelve months to $4.79M, down -0.19% year-over-year. In the fiscal year ending October 31, 2024, Zeo ScientifiX had annual revenue of $4.62M with 1.36% growth.
Revenue (ttm)
4.79M
Revenue Growth
-0.19%
P/S Ratio
1.96
Revenue / Employee
239.45K
Employees
20
Market Cap
9.36M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 4.62M | 62.00K | 1.36% |
Oct 31, 2023 | 4.56M | -1.93M | -29.78% |
Oct 31, 2022 | 6.49M | 893.52K | 15.96% |
Oct 31, 2021 | 5.60M | 2.54M | 83.18% |
Oct 31, 2020 | 3.06M | 1.35M | 79.51% |
Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Oct 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Tian'an Technology Group | 2.12M |
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
Zeo ScientifiX News
- 2 months ago - ZEO ScientifiX Positions for National Growth as Stem Cell Market Opens in Florida - Accesswire
- 3 months ago - ZEO ScientifiX Launches Physician-Focused Masterclass Ahead of Florida's SB-1768 Law Implementation - Accesswire
- 7 months ago - ZEO ScientifiX Strengthens Leadership Team With The Appointment of Dr. Peter Everts as Chief Scientific and Technology Officer - Accesswire
- 7 months ago - ZEO ScientifiX Provides Business Update to Stockholders and the Investment Community - Accesswire
- 11 months ago - ZEO ScientifiX and Exotropin Join Forces to Launch a Solution to Address the Growing Unmet Need for Hair Loss - Accesswire
- 1 year ago - ZEO ScientifiX, a Leading South Florida Biotechnology Company, Launches Regenerative Medicine Educational Series for Physicians - Accesswire
- 1 year ago - ZEO ScientifiX Partners with National Provider of Healthcare Services - Accesswire
- 1 year ago - ZEO ScientifiX is Moving Toward Its Goal of Transforming Healthcare Through Leading-Edge Research - Accesswire